INTRODUCTION {#sec1-1}
============

Diabetes mellitus is a growing and significant health problem strongly associated with obesity, and dyslipidemia. The increased energy intake and decreased physical activity are causing overweight and obesity, leading to an epidemic increase in the risk of type 2 diabetes. An increase in the consumption of high-sugar diets correlates positively with the development of diabetes.\[[@ref1]\] Scientific evidence clearly indicates that the consumption of edible plants enriched in polyphenolic compounds has been associated with a reduced risk of developing type 2 diabetes.\[[@ref2]--[@ref4]\] Especially, several studies have revealed that polyphenols may delay carbohydrate digestion and absorption by inhibiting α-glucosidase and α-amylase, consequently, reducing postprandial hyperglycemia which *may prevent development* of *diabetes mellitus*.\[[@ref5]--[@ref9]\]

Grape seed (*Vitis vinifera* Linn.) is an excellent source of various vitamins, minerals, and polyphenols including flavonoids, proanthocyanidins, and procyanidins.\[[@ref10]\] Numerous studies have shown that grape seed extract (GSE) have anti-platelet aggregation,\[[@ref11]\] antioxidant,\[[@ref12]\] cardioprotective activity,\[[@ref13]\] improvement of endothelial function,\[[@ref14]\] reduction of postprandial hypertriglyceridemia and hypercholesterolemia,\[[@ref15]\] and prevention of insulin resistance.\[[@ref16][@ref17]\] Moreover, GSE exhibits favorable inhibitory effect against intestinal α-glucosidases, pancreatic α-amylase activities.\[[@ref18]\] Another research has shown that GSE significantly improves markers of inflammation and glycemia and reduces plasma fructosamine in obese type 2 diabetic subjects.\[[@ref19]\] However, to date, there have been no studies examining the effects of GSE on postprandial plasma glucose. The present study was therefore conducted to determine the effect of GSE on postprandial plasma glucose in healthy subjects after a *high* carbohydrate *load* meal.

MATERIALS AND METHODS {#sec1-2}
=====================

Participants {#sec2-1}
------------

A total of nine healthy participants (five female and four male) were recruited from the staff and student populations at Faculty of Allied Health Science, Chulalongkorn University. One female subject was dropped out of the study because of her personal reason. At the screening visit, participant\'s health status was checked by routine blood chemistry test (blood glucose, total cholesterol, Low Density Lipoprotein \[LDL\]-cholesterol). A structured interview on habitual diet, previous and current diseases, medications use, alcohol consumption, physical activity, and dietary supplements use was implemented by dietitian. Participants were excluded from the study if they had any of the following: abnormal blood chemistry, history of metabolic disorder, taking medication or dietary supplement which would interfere with normal gastrointestinal function. The mean age was 21.25 ± 3.69 (female: 20.25 ± 0.96, male: 22.25 ± 5.32) years, BMI 20.28 ± 1.40 (female: 19.38 ± 0.91, male: 21.19 ± 1.25) kg/m^2^, and percent body fat 22.48 ± 6.24 (female: 24.97 ± 1.86, male: 19.98 ± 8.41). The randomized, controlled, and crossover trial was carried out. This study was conducted under approval of the Ethical Review Committee for Research Involving Human Research Participants, Health Science Group, Chulalongkorn University. Written informed consent was obtained from all study participants.

Study design {#sec2-2}
------------

One tablet GSE (100 mg) containing 95% proanthocyanidin was purchased from Natural Source™. Eight participants were randomly assigned into one of the three experiment tests including: high carbohydrate (HC) meal, HC meal + 100 mg GSE, and HC meal + 300 mg GSE (HC+ 300 mg GSE). The experiment began in the morning following an overnight fast. The fasting blood samples (3 ml) were collected in tubes EDTA-containing solution before an intake of test meal. Thereafter, the subjects were advised to consume the test meal within 5 min. The first bite in the mouth was set as time 0. Blood samples were taken at 15, 30, 45, 60, 90, and 120 min for laboratory analysis. Blood samples were immediately centrifuged (2,500 × *g*) and the plasma was separated and frozen at --20°C until analyzed for glucose concentration. Plasma glucose concentration was determined by glucose oxidase method by using an autoanalyzer at Service Unit, Faculty of Allied Health Sciences, Chulalongkorn University. Each test was conducted on a separate day and at least 2 week apart. Participants were requested to keep their lifestyles and body weight unchanged and to follow their habitual diet throughout the study.

Test meal {#sec2-3}
---------

A high carbohydrate meal consists of three slices of white bread, two table spoon of condense milk, and a cup of low fat milk (a total of 92 g carbohydrate, 8 g fat, and 14 g protein). This meal provided approximately 73.6 % carbohydrate.

Statistical analysis {#sec2-4}
--------------------

Data are expressed as means ± S.E.M. The incremental plasma glucose concentration curves were plotted as the change in incremental plasma glucose over time. The incremental changes in plasma glucose concentrations were calculated relative to fasting at all postprandial times. AUC was calculated according to the trapezoidal rule. Plasma glucose, incremental glucose concentration, and AUC of the different tests were compared using analysis of variance with Bonferroni correction for multiple comparisons. A *P*-value \< 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

The mean body weight, BMI, and percent body fat of all participants did not differ between the study population groups throughout the study. [Figure 1](#F1){ref-type="fig"} shows the effect of difference GSE doses (100 and 300 mg) on plasma glucose concentration. The peak plasma glucose concentration was reached at 30 min in HC meal (6.99 ± 0.55 mmol/L); HC meal + 100mg GSE: 5.63 ± 0.43 mmol/L, and HC meal + 300 mg GSE:5.75 ± 0.44 mmol/L). Results showed that postprandial plasma glucose concentrations at 15 min and 30 min in both HC + 100 mg GSE (5.33 ± 0.41 mmol/L and 5.62 ± 0.47 mmol/L, respectively) and HC + 300 mg GSE (5.27 ± 0.29 mmol/L, 5.75 ± 0.44 mmol/L, respectively) were significantly lower than those in HC meal. As shown in [Figure 2](#F2){ref-type="fig"}, the incremental postprandial plasma glucose concentration was also significantly decreased at 15 min after ingestion of 100 mg GSE (1.02 ± 0.37 mmol/L) and 300 mg GSE (0.59 ± 0.27 mmol/L) when compared to HC meal (2.13 ± 0.36 mmol/L). Intakes of HC meal plus GSE (100 and 300 mg) markedly reduced the AUC of glucose concentration by 46% and 75% (*P*\<0.05), respectively (AUC for HC meal = 134.09 ± 19.17 mmol/L. min; AUC for HC meal + GSE (100 mg) = 72.01 ± 19.2 mmol/L. min; AUC for HC meal + GSE (300 mg) = 33.8 8± 20.4 mmol/L.min) \[[Figure 3](#F3){ref-type="fig"}\].

![Plasma glucose concentration of high carbohydrate meal (•), HC meal + 100 mg GSE (∘), HC meal + 300 mg GSE (▼) in healthy participants (n=8). Values are means with standard error of the means represented by vertical bars. Mean value was significantly different from that of a HC meal: \**P* \< 0.05](PM-8-192-g001){#F1}

![Incremental plasma glucose concentration of high carbohydrate meal (•), a HC meal + 100 mg GSE (∘), a HC meal + 300 mg GSE (▼) in healthy participants (n=8). Values are means with standard error of the means represented by vertical bars. Mean value was significantly different from that of a HC meal. \**P* \< 0.05](PM-8-192-g002){#F2}

![Area Under the Curve (AUC) of plasma glucose concentration (mmol/L) of high carbohydrate (HC) meal and HC meal + GSE (100 and 300 mg) in healthy participants (n=8). Value was significantly different from that of a HC meal: \**P* \< 0.05](PM-8-192-g003){#F3}

DISCUSSION {#sec1-4}
==========

This study is the first to demonstrate the effect of GSE on postprandial hyperglycemia in healthy participants. The primary outcome in this study was the effect of grape seed extract on postprandial glucose levels. We found that the consumption of high carbohydrate meal together with GSE (100 and 300 mg) reduces postprandial glucose in healthy subjects after 15 min administration. In addition, only GSE (300 mg) can suppress postprandial glucose level after at 0 min of consumption. The secondary outcome in this study was measured plasma glucose AUC (0-120 min) after intake of high carbohydrate meal. Our findings indicate that the AUCs were markedly lowered after ingestion of GSE (100 and 300 mg) together HC meal than after ingestion of HC meal. *One of the limitations* of this *study* was the narrow age range of the subjects. While the small sample size of the study limit the generalizability of the results, a larger trial involving a greater number of patients would be needed to validate the findings of this small study.

Previous research by our group has demonstrated that GSE markedly inhibits the intestinal α-glucosidases, pancreatic α-amylase activities *in vitro*. Interestingly, proanthocyanidins, a major component in GSE, have shown potent intestinal α-glucosidase and pancreatic α-amylase inhibitory activities.\[[@ref18]\] It is possible that the reduced postprandial glycemia observed in the present study can be explained by the inhibitory activity of GSE proanthocyanidins against α-glucosidase and pancreatic α-amylase.

Much research has been focused on the control of postprandial glucose by the inhibition of pancreatic-amylase and the intestinal-glucosidases, the key enzymes of dietary carbohydrate digestion.\[[@ref20]\] The slowing carbohydrate digestion and/or absorption is the most probable mechanisms underlying potential the attenuated postprandial hyperglycemia, as this condition is associated with the prevention of impaired glucose tolerance (pre-diabetes) and *a significant reduction in risk of developing* type 2 diabetes.\[[@ref21][@ref22]\] Recently, it has been reported that the treatment with an α-glucosidase inhibitor (acarbose) specifically delays postprandial hyperglycemia, reduced the risk of type 2 diabetes.\[[@ref23]\] It is possible that consumption of GSE may prevent or delay developing type 2 diabetes in healthy people. The earlier evidence reports that suppression of postprandial glucose may contribute to decreasing the level of HbA~1c~ resulting in a significant reduction in the incidence of chronic vascular complication such as macro- and micro vascular diseases.\[[@ref24]\] Similarly, although this study included only healthy subjects, it may nevertheless apply to individuals with diabetes, as hyperglycemia is an independent predictor of future cardiovascular events in both healthy and diabetic individuals. Therefore, an intake of GSE might *help* people with type 2 diabetes mellitus control the postprandial hyperglycemia as thereby prevent the progression of diabetic complications.

Kar *et al* reported that after four weeks administration of GSE (600 mg/day) to diabetic patients, fructosamine was significantly decreased when compared to the basal level.\[[@ref19]\] The fructosamine levels are used to access glycemic control since they can indicate the accumulation of early (Amadori) glycation products in diabetic patients. The reduction of fructosamine level can prevent the progression of diabetic complications. The recently published showed that GSE (200 mg/day) did not reduce plasma glucose and HbA~1C~ level in diabetic patients after two months of supplementation.\[[@ref25]\] However, the effect of GSE on postprandial glucose and HbA~1C~ level in diabetic patients remains controversial. *Further studies* would be *needed* to determine the effect of GSE in diabetic subjects focusing on examining postprandial glucose and HbA~1C~ level which could yield important new insights into the preventive of diabetic complications.

CONCLUSION {#sec1-5}
==========

GSE markedly reduces postprandial plasma glucose in healthy participants after consuming a high carbohydrate meal which suggests it may be a useful addition to other strategies aimed to prevent development of diabetes in the healthy population.
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